Literature DB >> 2083226

Regulation of interleukin 4 receptors on human T cells.

R J Armitage1, M P Beckmann, R L Idzerda, A Alpert, W C Fanslow.   

Abstract

Human recombinant interleukin 4 (IL-4) was modified with biotin-N-hydroxysuccinimide and used to examine the expression of human IL-4 receptors (IL-4R) on activated peripheral blood T cells by flow cytometry. Freshly isolated T cells expressed only a low level of IL-4R which remained unchanged when cells were cultured in the absence of stimuli. In the presence of IL-4, IL-7, phytohemagglutinin A (PHA), or immobilized CD3 mAb the intensity of biotinylated IL-4 staining increased approximately 2-fold on the majority of cells. A combination of mitogen with either IL-4 or IL-7 caused an increase in receptor expression over that seen in the presence of mitogen alone. IL-2 alone failed to induce IL-4R, although it was able to induce a significant increase in receptor expression on T cells co-cultured with PHA or CD3 mAb. Flow cytometric analysis of purified T cell subsets confirmed that the up-regulation of IL-4R occurred on both CD4+ and CD8+ subpopulations. Two-color staining of T cells activated with PHA and IL-7 revealed that this increase in IL-4R expression occurred almost exclusively on cells expressing the p55 IL-2Ra subunit, although a significant number of cells expressing p55 do not express IL-4R. Analysis of IL-4R expression by this flow cytometric technique was substantiated by 125I-labeled IL-4 binding data and Northern blot analysis of IL-4R mRNA levels, suggesting that use of biotinylated human IL-4 for ligand binding and its detection by flow cytometry provides a very sensitive method for the study of IL-4R regulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2083226     DOI: 10.1093/intimm/2.11.1039

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Authors:  L D Strockbine; J I Cohen; T Farrah; S D Lyman; F Wagener; R F DuBose; R J Armitage; M K Spriggs
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes.

Authors:  M I de Moraes-Pinto; G S Vince; B F Flanagan; C A Hart; P M Johnson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

3.  Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis.

Authors:  Marat V Khodoun; Richard Strait; Laura Armstrong; Noriko Yanase; Fred D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

4.  CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

Authors:  H J Gruss; A Pinto; A Gloghini; E Wehnes; B Wright; N Boiani; D Aldinucci; V Gattei; V Zagonel; C A Smith; M E Kadin; C von Schilling; R G Goodwin; F Herrmann; A Carbone
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Inhibition of IL-4 receptor up-regulation on B cells by antisense oligodeoxynucleotide suppresses IL-4-induced human IgE production.

Authors:  K Ikizawa; K Kajiwara; T Koshio; N Matsuura; Y Yanagihara
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

6.  Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation.

Authors:  Suzanne C Morris; Stephanie M Heidorn; De'Broski R Herbert; Charles Perkins; David A Hildeman; Marat V Khodoun; Fred D Finkelman
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

7.  Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis.

Authors:  E J Feron; V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

8.  Thymus reconstitution by c-kit-expressing hematopoietic stem cells purified from adult mouse bone marrow.

Authors:  P de Vries; K A Brasel; H J McKenna; D E Williams; J D Watson
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.